Company profile for Laboratorios Salvat

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Laboratorios Salvat, founded in Barcelona in 1955, is a privately owned pharmaceutical company currently overseen by the third and fourth generations of the family. Our commitment as a company is directed towards organic expansion, driven by a steadfast long-term perspective aimed at fostering innovation and employment. Ethical considerations form the foundation of our family-managed business. With over 400 employees in Spain,...
Laboratorios Salvat, founded in Barcelona in 1955, is a privately owned pharmaceutical company currently overseen by the third and fourth generations of the family. Our commitment as a company is directed towards organic expansion, driven by a steadfast long-term perspective aimed at fostering innovation and employment. Ethical considerations form the foundation of our family-managed business. With over 400 employees in Spain, manufacturing facilities in Barcelona, Madrid, and Tamarac (Florida), two successfully marketed products in the United States, and a substantial global footprint, we anticipate a promising future for Salvat.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Esplugues de Llobregat Barcelona
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://svt.com/en/salvat-laboratories-presented-phase-iii-clinical-trials-results-of-clobetasol-nanoemulsion-for-treating-inflammation-and-pain-after-ocular-surgery-at-the-2023-arvo-annual-meeting/

PRESS RELEASE
24 Apr 2023
Salvat Laboratories Submits NDA to FDA
Salvat Laboratories Submits NDA to FDA

31 Oct 2022

// CONTRACTPHARMA

https://www.contractpharma.com/contents/view_breaking-news/2022-10-31/salvat-laboratories-submits-nda-to-fda/9769

CONTRACTPHARMA
31 Oct 2022

https://www.fiercepharma.com/pharma/salvat-heads-regulators-phase-3-data-ocular-steroid

N.P. Taylor FIERCEPHARMA
13 Apr 2022
Salvat heads to regulators with phase 3 data on ocular steroid
Salvat heads to regulators with phase 3 data on ocular steroid

12 Apr 2022

// Nick Paul Taylor FIERCEPHARMA

https://www.fiercepharma.com/pharma/salvat-heads-regulators-phase-3-data-ocular-steroid

Nick Paul Taylor FIERCEPHARMA
12 Apr 2022

https://www.prnewswire.com/news-releases/global-glaucoma-pipeline-guide-h1-2020--provides-data-for-therapeutics-under-development-by-stage-of-development-drug-target-mechanism-of-action-route-of-administration-and-molecule-type-301045394.html

PRNEWSWIRE
22 Apr 2020

https://www.oaoa.com/news/business/article_24e530cc-5160-59d0-9e29-7a6e0be86657.html

OAOA
21 Apr 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty